Table 2.
Base-line | 1 weeks | 2 weeks | 3 weeks | 6 weeks | 9 weeks | 3 Month | 6 Month | 9 Month | 12 Month | 15 Month | 18 Month | 21 Month | 24 Month | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical assessment | ||||||||||||||||
Socio-demographic characteristics | √ | |||||||||||||||
Psychological characteristics | ||||||||||||||||
Personality | √ | √ | √ | |||||||||||||
Social support | √ | √ | √ | √ | ||||||||||||
Stress-related status | √ | √ | √ | √ | ||||||||||||
Outcomes of depression | ||||||||||||||||
Depressive symptom | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
Functional disability | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
Suicidality | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
Quality of life | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
Biological assessment | ||||||||||||||||
Blood biomarker | √ | √ | ||||||||||||||
Salivary cortisol (cortisol study only) | √ | √ | √ | √ | √ | |||||||||||
Electrocardiography | √ | √ | ||||||||||||||
Resting BP, body mass index | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |||||
Treatment related assessment | ||||||||||||||||
Antidepressants, dosage, duration | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
Adverse events | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
Withdrawal | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
MAKE BETTER: MAKE Biomarker discovery for Enhancing anTidepressants Treatment Effect and Response, BP: blood pressure